Literature DB >> 19652356

Crystallization and preliminary X-ray analysis of a complex formed between the antibiotic simocyclinone D8 and the DNA breakage-reunion domain of Escherichia coli DNA gyrase.

Marcus J Edwards1, Ruth H Flatman, Lesley A Mitchenall, Clare E M Stevenson, Anthony Maxwell, David M Lawson.   

Abstract

Crystals of a complex formed between the 59 kDa N-terminal fragment of the Escherichia coli DNA gyrase A subunit (also known as the breakage-reunion domain) and the antibiotic simocyclinone D8 were grown by vapour diffusion. The complex crystallized with I-centred orthorhombic symmetry and X-ray data were recorded to a resolution of 2.75 A from a single crystal at the synchrotron. DNA gyrase is an essential bacterial enzyme and thus represents an attractive target for drug development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652356      PMCID: PMC2720350          DOI: 10.1107/S1744309109028097

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  13 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

Review 2.  Thirty years of Escherichia coli DNA gyrase: from in vivo function to single-molecule mechanism.

Authors:  Marcelo Nöllmann; Nancy J Crisona; Paola B Arimondo
Journal:  Biochimie       Date:  2007-02-24       Impact factor: 4.079

Review 3.  DNA topoisomerases: harnessing and constraining energy to govern chromosome topology.

Authors:  Allyn J Schoeffler; James M Berger
Journal:  Q Rev Biophys       Date:  2008-02       Impact factor: 5.318

Review 4.  DNA gyrase as a drug target.

Authors:  A Maxwell
Journal:  Trends Microbiol       Date:  1997-03       Impact factor: 17.079

5.  Crystal structure of the breakage-reunion domain of DNA gyrase.

Authors:  J H Morais Cabral; A P Jackson; C V Smith; N Shikotra; A Maxwell; R C Liddington
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

6.  Simocyclinones, novel cytostatic angucyclinone antibiotics produced by Streptomyces antibioticus Tü 6040. I. Taxonomy, fermentation, isolation and biological activities.

Authors:  J Schimana; H P Fiedler; I Groth; R Süssmuth; W Beil; M Walker; A Zeeck
Journal:  J Antibiot (Tokyo)       Date:  2000-08       Impact factor: 2.649

7.  Simocyclinone D8, an inhibitor of DNA gyrase with a novel mode of action.

Authors:  Ruth H Flatman; Alison J Howells; Lutz Heide; Hans-Peter Fiedler; Anthony Maxwell
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 8.  The ATP-binding site of type II topoisomerases as a target for antibacterial drugs.

Authors:  Anthony Maxwell; David M Lawson
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

Review 9.  The integration of macromolecular diffraction data.

Authors:  Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  2 in total

1.  Identification of novel bacterial DNA gyrase inhibitors: An in silico study.

Authors:  Hamzeh Rahimi; Ali Najafi; Habib Eslami; Babak Negahdari; Mehrdad Moosazadeh Moghaddam
Journal:  Res Pharm Sci       Date:  2016 May-Jun

Review 2.  Structural insights into simocyclinone as an antibiotic, effector ligand and substrate.

Authors:  Mark J Buttner; Martin Schäfer; David M Lawson; Anthony Maxwell
Journal:  FEMS Microbiol Rev       Date:  2018-01-01       Impact factor: 16.408

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.